Autopsy report · NCT00491751

Clinical Utility of Endothelial Dysfunction in PAD

“Insufficient enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 years 1 month after it had already started.
• Ran for about 8 years 1 month before it stopped.
• 108 participants enrolled.
• Results were posted on the registry 6 years 1 month after it ended.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Boston University

Sponsor type

University, hospital or other

Conditions

Peripheral Arterial Disease

Interventions

atorvastatin; ascorbic acid; Placebo

Participants

108

Sites

1

Countries

United States

Trials that died the same way

• Cellular Immunotherapy Treatment Antigen-Directed for EBV Lymphoma
  “Insufficient enrollment rate” (91% match in meaning)
• Treatment Prior to Injection and Biopsy of the Vulva
  “Not enough enrollment” (91% match in meaning)
• Family Nurture Intervention in the CHoNJ NICU
  “insufficient enrollment numbers” (91% match in meaning)
• Development of Auditory Skills in Young Deaf Children With Bilateral Cochlear Implants
  “Not sufficient enrollment” (89% match in meaning)
• Does Ultrasound Help Junior Anesthesia Residents With Placement of Labor Analgesia in Pregnant Patients
  “lack of enrollment” (89% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.